In summary, we comprehensively analyzed the molecular profiling of B-cell lymphoma and found that SEPT6_TRIM33 fusion gene, mutations in single TP53 gene, mutated TP53 and Hippo pathways would together predict inferior prognosis for B-cell lymphomas. The gene discussed is TRIM33; the disease is B-cell non-Hodgkin lymphoma.